Acceleron Pharma Inc

Ownership Transactions Reported by 13 Insiders

Industry: Biological Products, (No Diagnostic Substances)
Location: 128 Sidney Street, Cambridge, MA

There are no Buy or Sell transactions made by insiders since 3/8/2024

Acceleron Pharma Inc executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Sujay Kango	EVP, Chief Commercial Officer				Nov 19, 2021
Joseph S. Zakrzewski	Director				Nov 19, 2021
Adam M. Veness	SVP, General Counsel and Sec.				Nov 19, 2021
Thomas A. MCCOURT	Director				Nov 19, 2021
Kemal Malik	Director				Nov 19, 2021
Jay T. Backstrom	EVP, Research and Development				Nov 19, 2021
Kevin Mclaughlin	SVP, CFO and Treasurer				Nov 19, 2021
Karen L. Smith	Director				Nov 19, 2021
Francois Nader	Director				Nov 19, 2021
Laura Hamill	Director				Nov 19, 2021
Terrence C. Kearney	Director				Nov 19, 2021
Christopher Hite	Director				Nov 19, 2021
Habib J. Dable	CEO and President, Director				Nov 19, 2021

Showing 1 to 13 of 13 entries

Recent Insider Transactions by Companies or Individuals for Acceleron Pharma Inc

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.